Prednisolone plus albuterol versus albuterol alone in mild to moderate bronchiolitis

Clinical Pediatrics

Volumn 39, Issue 4, 2000, Pages 213-220

  Goebel, Jens ^a,b   Estrada, Benjamin ^a   Quinonez, Jorge ^a   Nagji, Noorkarim ^a   Sanford, David ^a   Boerth, Robert C ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; PLACEBO; PREDNISOLONE; SALBUTAMOL;

ARTICLE; BREATHING RATE; BRONCHIOLITIS; CHILD HOSPITALIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS CULTURE; VIRUS INFECTION; WHEEZING;

EID: 0033994985     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280003900404     Document Type: Article

References (28)

1. Welliver JR, Welliver RC. Bronchiolitis. Pediatr Rev. 1993:14:134-139.
2. La Via WV, Marks MI, Stutman HR. Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment, and prevention. J Pediatr. 1992;121:503-510.
3. Long SS. Respiratory syncytial virus. In: Oski FA, ed. Principles and Practice of Pediatrics. 1st ed. Philadelphia: JB Lippincott Co; 1990:1189-1192.
4. Hall CB. Respiratory syncytial virus: what we know now. Contemp Pediatr. 1993;10:92-110.
5. Kellner JD, Ohlsson A, Gadomski AM, Wang EEL. Efficacy of bronchodilator therapy in brochiolitis. Arch Pediatr Adolesc Med. 1996;150:1166-1172.
6. 2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics. 1997; 100:233-239.
7. Richter H, Seddon P. Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing. J Pediatr. 1998;132:849-853.
8. Reijonen T, Korppi M, Kuikka L, Remes K. Anti-inflammatory therapy reduces wheezing after bronchiolitis. Arch Pediatr Adolesc Med. 1996;150:512-517.
9. Szefler SJ. Glucocorticoid therapy for asthma: clinical pharmacology. J Allergy Clin Immunol. 1991;88:147-165.
10. Tal A, Bavilski C, Yohai D, et al. Dexamethsone and salbutamol in the treatment of acute wheezing in infants. Pediatrics. 1983;71:13-18.
11. Klassen TP, Sutcliffe T, Watters LK, et al. Dexamethasone in salbutamol-treated inpatients with acute bronchiolitis: a randomized, controlled trial. J Pediatr. 1997;130:191-196.
12. Mallol J, Barrueto L, et al. Use of nebulized bronchiodilators in infants under 1 year of age: analysis of four forms of therapy. Pediatr Pulmonol. 1987;3:298-303.
13. Roosevelt G, Sheehan K, Grupp-Phelan J, et al. Dexamethasone in bronchiolitis: a randomized controlled trial. Lancet. 1996;348:292-295.
14. Loughlin GM. Bronchitis and bronchiolitis. In: Burg FC, Ingelfinger JR, Polin RA, Wald ER, eds. Gellis & Kagan's Current Pediatric Therapy. 15th ed. Philadelphia: WB Saunders Co; 1996:136-138.
15. Nicolai T, Pohl A. Acute viral bronchiolitis in infancy: epidemiology and mangement. Lung. 1990:396-405 (Suppl).
16. Wang EEL, Law BJ, Boucher FD, et al. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr. 1996;129:390-395.
17. Kimpen JLL, Schaad UB. Treatment of respiratory syncytial virus bronchiolitis: 1995 poll of members of the European Society for Pediatric infectious Diseases. Pediatr Infect Dis J. 1997; 16:479-481.
18. Truhan AP, Ahmed AR. Corticosteroids: a review with emphasis on complications of prolonged systemic therapy. Ann Allergy 1989;62:375-390.
19. Gadomski AM, Aref GH, El Din OB, et al. Oral versus nebulized albuterol in the management of bronchiolitis in Egypt. J Pediatr. 1994;124:131-138.
20. McIntosh K. Respiratory syncytial virus. In: Behrman RE, Kliegman RM, Arvin AM, eds. Nelson Textbook of Pediatrics. 15th ed. Philadelphia: WB Saunders Co; 1996:904-906.
21. Etzel RA, Pattishall EN, Haley NJ, et al. Passive smoking and middle ear effusion among children in day care. Pediatrics. 1992;90:228-232.
22. Chilmonczyk BA, Palomaki GE, Knight GJ, et al. An unsuccessful cotinine-assisted intervention strategy to reduce environmental tobacco smoke exposure during infancy. Am J Dis Child. 1992;146:357-360.
23. Menon K, Sutcliffe T, Klassen TP. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. J Pediatr. 1995;126:1004-1007.
24. Sanchez I, De Koster J, Powell RE, et al. Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics in infants with bronchiolitis. J Pediatr. 1993;122:145-151.
25. Shahar EM, Hwang PA, Niesen CE, Murphy EG. Poliomyelitis-like paralysis during recovery from acute bronchial asthma: possible etiology and risk factors. Pediatrics 1991;88: 276-279.
26. Reiches NA, Jones JF. Steroids and varicella. Pediatrics. 1993:92:288-289.
27. Ray CG, Minnich LL, Holberg CJ, et al, and the Group Health Medical Associates. Respiratory syncytial virus-associated lower respiartory illness: possible influence of other agents. Pediatr Infect Dis J. 1993;12:15-19.
28. Kuppermann N, Bank DE, Walton EA, et al. Risk of occult bacterial infection in febrile infants with bronchiolitis. Arch Pediatr Adolesc Med. 1996;12:329-330 (abstract).